[1] 黄希顺,廖卫平,李世绰,等.丙戊酸镁缓释片治疗癫痫临床应用专家共识[J], 癫痫与神经电生理杂志,2013,22(1):1-12.
[2] GLAUSER T,SHINNAR S,GLOSS D,et al.Evidence-based guideline:treatment of convulsive status epilepticus in children and adults:report of the Guideline Committee of the American Epilepsy Society[J].Epilepsy Curr,2016,16(1):48-61.
[3] KAYIHAN N,NENNESMO I,ERICZON BG,et al.Fatal deterioration of neurological disease after orthotopic liver transplantation for valproic acid-induced liver damage[J].Pediatr Transplant,2000,4(3):211-214.
[4] ANTONIUK SA,BRUCK I,HÖNNICKE LR,et al.Acute hepatic failure associated with valproic acid in children.Report of 3 cases[J]Arq Neuropsiquiatr,1996,54(4):,652-654.
[5] DICKINSON RG, BASSETT ML, SEARLE J,et al.Valproate hepatotoxicity:a review and report of two instances in adults[J].Clin Exp Neurol,1985,21,79-91.
[6] SHAABAN AA,EL-AGAMY DS.Cytoprotective effects of diallyl trisulfide against valproate-induced hepatotoxicity:new anticonvulsant strategy[J].Naunyn Schmiedebergs Arch Pharmacol,2017,390(9):919-928.
[7] AHMED N,ALJUHANI N,AL-HUJAILI HS,et al.Agmatine protects against sodium valproate-induced hepatic injury in mice via modulation of nuclear factor-KB/inducible nitric oxide synthetase pathway[J].J Biochem Mol Toxicol,2018,32(12):e22227.
[8] 魏树礼.生物药剂学与药物动力学[M].北京:北京医科大学·中国协和医科大学联合出版社,1997:114.